Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


30.01.2017

1 Ann Intern Med
4 Arch Virol
2 BMJ
1 Infect Immun
1 J Gen Virol
1 J Infect
1 J Virol
2 JAMA
3 Lancet Infect Dis
2 Pediatr Infect Dis J
12 PLoS One
1 Proc Natl Acad Sci U S A
14 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. SACKS HS
    In adults >/= 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years.
    Ann Intern Med. 2017;166:JC5.
    PubMed     Text format    


    Arch Virol

  2. MIAO FM, Zhang SF, Wang SC, Liu Y, et al
    Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available

  3. NAVID MT, Li Y, Zhou M, Cui M, et al
    Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available

  4. ZHOU Y, Yang X, Wang H, Zeng F, et al
    The establishment and characteristics of cell-adapted IBV strain H120.
    Arch Virol. 2016;161:3179-87.
    PubMed     Text format     Abstract available

  5. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


    BMJ

  6. GOLDBERG A
    Link between flu vaccines and narcolepsy still needs investigating.
    BMJ. 2017;356:j137.
    PubMed     Text format    

  7. GULLAND A
    Gates launches $1bn vaccine initiative to target emerging infectious diseases.
    BMJ. 2017;356:j330.
    PubMed     Text format    


    Infect Immun

  8. GARVY BA
    Overcoming hurdles to vaccine development against Pneumocystis jirovecii.
    Infect Immun. 2017 Jan 23. pii: IAI.00035-17. doi: 10.1128/IAI.00035.
    PubMed     Text format     Abstract available


    J Gen Virol

  9. GRANT CF, Carr BV, Singanallur NB, Morris J, et al
    The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.
    J Gen Virol. 2016 Dec 9:1-8. doi: 10.1099/jgv.0.000517.
    PubMed     Text format     Abstract available


    J Infect

  10. WOESTENBERG PJ, King AJ, van der Sande MA, Donken R, et al
    No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    J Infect. 2017 Jan 23. pii: S0163-4453(17)30026.
    PubMed     Text format     Abstract available


    J Virol

  11. ROYER DJ, Carr MM, Chucair-Elliott AJ, Halford WP, et al
    Impact of type 1 interferon on the safety and immunogenicity of an experimental live-attenuated herpes simplex virus type 1 vaccine in mice.
    J Virol. 2017 Jan 25. pii: JVI.02342-16. doi: 10.1128/JVI.02342.
    PubMed     Text format     Abstract available


    JAMA

  12. ABBASI J
    Large HIV Vaccine Trial Launches in South Africa.
    JAMA. 2017;317:350.
    PubMed     Text format    

  13. HALABI SF, Omer SB
    A Global Vaccine Injury Compensation System.
    JAMA. 2017 Jan 23. doi: 10.1001/jama.2016.19492.
    PubMed     Text format    


    Lancet Infect Dis

  14. PLETZ MW, Kamradt T, Welte T
    Time to follow up when comparing studies of pneumococcal vaccines.
    Lancet Infect Dis. 2017 Jan 23. pii: S1473-3099(17)30051.
    PubMed     Text format    

  15. PARKER LA, Rumunu J, Jamet C, Kenyi Y, et al
    Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.
    Lancet Infect Dis. 2017 Jan 18. pii: S1473-3099(16)30472.
    PubMed     Text format     Abstract available

  16. SUZUKI M, Dhoubhadel BG, Ishifuji T, Yasunami M, et al
    Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.
    Lancet Infect Dis. 2017 Jan 23. pii: S1473-3099(17)30049.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  17. CHUN CHAU JP, Lo SH, Chow Choi K, Kin Chau MH, et al
    Factors Determining the Uptake of Influenza Vaccination Among Children with Chronic Conditions.
    Pediatr Infect Dis J. 2017 Jan 19. doi: 10.1097/INF.0000000000001550.
    PubMed     Text format     Abstract available

  18. KUROSKY SK, Davis KL, Galindo CM
    Effect of Combination Vaccines on Hepatitis B Vaccine Compliance in Children in the United States.
    Pediatr Infect Dis J. 2017 Jan 17. doi: 10.1097/INF.0000000000001548.
    PubMed     Text format     Abstract available


    PLoS One

  19. SCHMID P, Rauber D, Betsch C, Lidolt G, et al
    Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.
    PLoS One. 2017;12:e0170550.
    PubMed     Text format     Abstract available

  20. SECORE S, Wang S, Doughtry J, Xie J, et al
    Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    PLoS One. 2017;12:e0170640.
    PubMed     Text format     Abstract available

  21. HAYWARD AC
    Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients.
    PLoS One. 2017;12:e0169023.
    PubMed     Text format    

  22. DE SERRES G, Skowronski DM, Ward BJ, Gardam M, et al
    Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
    PLoS One. 2017;12:e0163586.
    PubMed     Text format     Abstract available

  23. HJALMARSDOTTIR MA, Quirk SJ, Haraldsson G, Erlendsdottir H, et al
    Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    PLoS One. 2017;12:e0169210.
    PubMed     Text format     Abstract available

  24. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available

  25. MA L, Wang X, Bi X, Yang J, et al
    Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.
    PLoS One. 2017;12:e0170479.
    PubMed     Text format     Abstract available

  26. BURGHOUTS J, Del Nogal B, Uriepero A, Hermans PW, et al
    Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach.
    PLoS One. 2017;12:e0170227.
    PubMed     Text format     Abstract available

  27. FU Y, Li P, Cao Y, Wang N, et al
    Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine.
    PLoS One. 2017;12:e0170560.
    PubMed     Text format     Abstract available

  28. AIYEGBO MS, Shmelkov E, Dominguez L, Goger M, et al
    Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic alpha-Helical Structure.
    PLoS One. 2017;12:e0170530.
    PubMed     Text format     Abstract available

  29. LI K, Wei G, Cao Y, Li D, et al
    The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine.
    PLoS One. 2017;12:e0170575.
    PubMed     Text format     Abstract available

  30. MOISI JC, Makawa MS, Tall H, Agbenoko K, et al
    Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
    PLoS One. 2017;12:e0170412.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  31. BAKKER KM, Martinez-Bakker ME, Helm B, Stevenson TJ, et al
    Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.
    Proc Natl Acad Sci U S A. 2016;113:6689-94.
    PubMed     Text format     Abstract available


    Vaccine

  32. QUINN SC, Jamison A, Freimuth VS, An J, et al
    Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adults.
    Vaccine. 2017 Jan 13. pii: S0264-410X(16)31271.
    PubMed     Text format     Abstract available

  33. WIJAYA L, Tham CY, Chan YF, Wong AW, et al
    An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.
    Vaccine. 2017 Jan 21. pii: S0264-410X(16)31256.
    PubMed     Text format     Abstract available

  34. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.
    PubMed     Text format    

  35. JONES RM, Burke M, Dubose D, Chichester JA, et al
    Stability and pre-formulation development of a plant-produced anthrax vaccine candidate.
    Vaccine. 2017 Jan 20. pii: S0264-410X(16)31206.
    PubMed     Text format     Abstract available

  36. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available

  37. SCHEIBLHOFER S, Strobl A, Hoepflinger V, Thalhamer T, et al
    Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30058.
    PubMed     Text format     Abstract available

  38. XIAO Y, Daniell H
    Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
    Vaccine. 2017 Jan 19. pii: S0264-410X(16)31295.
    PubMed     Text format     Abstract available

  39. POSTON TB, Gottlieb SL, Darville T
    Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30042.
    PubMed     Text format     Abstract available

  40. WALZ PH, Givens MD, Rodning SP, Riddell KP, et al
    Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-liv
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30009.
    PubMed     Text format     Abstract available

  41. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Text format     Abstract available

  42. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Text format     Abstract available

  43. WEINBERG M, Dietz S, Potter R, Swanson R, et al
    Vaccine shot-limiting: Estimating the prevalence, indicators, and impact on vaccination status - Michigan, 2012.
    Vaccine. 2017 Jan 17. pii: S0264-410X(17)30019.
    PubMed     Text format     Abstract available

  44. SUNDARAM N, Chen C, Yoong J, Luvsan ME, et al
    Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30010.
    PubMed     Text format     Abstract available

  45. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Text format     Abstract available


    Virology

  46. KIM SH, Paldurai A, Samal SK
    A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
    Virology. 2017;503:31-36.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: